Fyn has been shown to associate with BCR-ABL1 and regulate its signaling through phosphorylation of the SH2 and SH3 domains suggesting that Fyn kinase activity is elevated in CML [21], [43]. This evidence concerns the gene ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive.